Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | 37,357 | 40,644 | 22.32% | +3,287 |
| Entrada Therapeutics, Inc. | 4,425,784 | 4,425,784 | 0 | 62,713 | 63,067 | 34.64% | +354 |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | 10,563 | 7,401 | 4.06% | -3,162 |
| Adaptimmune Therapeutics plc | 5,555,461 | 5,555,461 | 0 | 8,778 | 5,417 | 2.97% | -3,361 |
| Werewolf Therapeutics, Inc. | 4,284,172 | 4,284,172 | 0 | 27,761 | 10,453 | 5.74% | -17,308 |
| Dyne Therapeutics, Inc.(DYN) | 3,451,303 | 1,561,496 | -1,889,807 | 97,982 | 55,105 | 30.26% | -42,877 |